MABN389 Anti-Aggregated a-Synuclein Antibody, clone 5G4

100 µg  
Retrieving price...
Price could not be retrieved
Minimum Quantity needs to be mulitiple of
Upon Order Completion More Information
You Saved ()
Request Pricing
Limited AvailabilityLimited Availability
Limited Quantities Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Special Offers


      Contact Customer Service


      Replacement Information

      Key Specifications Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      H WB, IHC, ELISA M Affinity Purified Monoclonal Antibody
      Catalogue NumberMABN389
      DescriptionAnti-Aggregated a-Synuclein Antibody, clone 5G4
      Alternate Names
      • Aggregated a-synuclein
      • Alpha-synuclein
      • Non-A beta component of AD amyloid
      • Non-A4 component of amyloid precursor
      • NACP
      Background Informationα-Synuclein, also known as Non-A beta component of AD amyloid or Non-A4 component of amyloid, or NACP, and encoded by the gene SNCA/NACP/PARK1, is a protein originally identified as non-Abeta component protein (NACP) in the amyloid enriched fraction isolated from Alzheimer’s brain tissue. α-Synuclein is expressed in neural tissue and non-neural tissues too. In neurons, α-Synuclein is localized to the nucleus, presynaptic termini and mitochondria of certain brain regions. α-Synuclein is a molecular chaperone that binds various proteins and compounds including synaptobrevin-2 protein and membrane phospholipids and is involved in vesicle trafficking and membrane transport within neurons. Natural, non-mutated α-Synuclein has autoproteolytic activity and naturally forms stable alpha helical tetramers. However, mutated α-Synuclein can aggregate to form insoluble pathological complexes such as Lewy Bodies inside neurons. Lewy Bodies also contain ubiquitin and it is thought that they are evidence of disrupted proteasome function with regards to α-synuclein but research is still continuing.
      Pepscan epitope mapping experiments showed that the epitope of 5G4 seems to be hidden inside full-length a-synuclein in aqueous solution, and this fact could depend on a specific conformation of the molecule. Thus, after conformational change, like b-sheet building, the binding structure of 5G4 may be accessible in biological samples.
      This antibody can be used as a sandwich ELISA pair with Cat. No. MABN633, Anti-a-Synuclein, clone 10D2.
      Product Information
      FormatAffinity Purified
      PresentationPurified mouse monoclonal IgG1κ in buffer containing PBS without preservatives.
      ApplicationThis Anti-Aggregated a-Synuclein Antibody, clone 5G4 is validated for use in western blotting, IHC & ELISA for the detection of Aggregated a-Synuclein.
      Key Applications
      • Western Blotting
      • Immunohistochemistry
      • ELISA
      Application NotesWestern Blotting Analysis: 2 µg/mL from a representative lot detected Aggregated a-Synuclein in human brain tissue lysate.

      ELISA Analysis: A representative lot from an independent laboratory detected Aggregated a-Synuclein in a sandwich ELISA with Cat. No. MABN633, Anti-a-Synuclein, clone 5G4 (Kovacs, G. G., et al. (2012). Acta Neuropathol. 123(1):37-50.).
      Biological Information
      ImmunogenKLH-conjugated linear peptide corresponding to human Aggregated a-Synuclein.
      ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • SNCA
      • NACP
      • PARK1
      Purification MethodAffinity Purfied
      UniProt Number
      Molecular Weight~15 kDa observed. Uncharacterized band(s) may be observed in some cell lysates.
      Physicochemical Information
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Immunohistochemistry in brain tissue from a Parkinson's disease patient.

      Immunohistochemistry Analysis: A representative lot detected Aggregated a-Synuclein in brain tissue from a Parkinson's disease patient.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at -20°C from date of receipt.
      Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
      Packaging Information
      Material Size100 µg
      Transport Information
      Supplemental Information


      Anti-Aggregated a-Synuclein Antibody, clone 5G4 SDS


      Safety Data Sheet (SDS) 

      Anti-Aggregated a-Synuclein Antibody, clone 5G4 Certificates of Analysis

      TitleLot Number
      Anti-Aggregated a-Synuclein, clone -VP1412161VP1412161
      Anti-Aggregated a-Synuclein, clone -VP15100026VP15100026
      Anti-Aggregated a-Synuclein, clone -VP1512070VP1512070
      Anti-Aggregated a-Synuclein, clone -VP1606270VP1606270
      Anti-Aggregated a-Synuclein, clone 5G4VP1611151
      Anti-Aggregated a-Synuclein, clone 5G4VP1407100
      Anti-Aggregated a-Synuclein, clone 5G4 - QVP1310071QVP1310071
      Anti-Aggregated a-Synuclein, clone 5G4 - VP1801021VP1801021
      Anti-Aggregated a-Synuclein, clone 5G4 - VP1901030VP1901030
      Anti-Aggregated a-Synuclein, clone 5G4 - VP1907160VP1907160


      Reference overviewPub Med ID
      Clinical neuropathology
      Unterberger, U; Lachmann, I; Voigtländer, T; Pirker, W; Berghoff, AS; Flach, K; Wagner, U; Geneste, A; Perret-Liaudet, A; Kovacs, GG
      Clinical neuropathology  33  329-34  2014

      Show Abstract
      25131945 25131945
      Intracellular processing of disease-associated α-synuclein in the human brain suggests prion-like cell-to-cell spread.
      Kovacs, GG; Breydo, L; Green, R; Kis, V; Puska, G; Lőrincz, P; Perju-Dumbrava, L; Giera, R; Pirker, W; Lutz, M; Lachmann, I; Budka, H; Uversky, VN; Molnár, K; László, L
      Neurobiology of disease  69  76-92  2014

      Show Abstract
      24878508 24878508
      In vivo markers of Parkinson's disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody.
      Maetzler, W; Pilotto, A; Apel, A; Deuschle, C; Kuebart, G; Heinzel, S; Liepelt-Scarfone, I; Schulte, C; Reusch, D; Schleicher, E; Rothfuss, O; Schneider, A; Dodel, R; Gasser, T; Berg, D
      Acta neuropathologica  128  893-5  2014

      25376537 25376537
      An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology.
      Kovacs, Gabor G, et al.
      Acta Neuropathol., 124: 37-50 (2012)  2012

      Show Abstract
      22370907 22370907

      Related Products & Applications

      Related Products


      Life Science Research > Antibodies and Assays > Primary Antibodies